Chung-Il Joung
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Chung-Il Joung has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
- Mihye Kwon
Department of Internal Medicine, College of Medicine, Konyang University, Daejeon, South Korea
4 shared publications - Seonghui Kang
Department of Internal Medicine Konyang University Hospital Daejeon Republic of Korea
2 shared publications - Chung Chun Lee
Department of Biomedical Informatics, College of Medicine, Konyang University, Daejeon, Republic of Korea
1 shared publication - Ga Hyun Lee
Department of Dermatology Konyang University Hospital Daejeon Republic of Korea
1 shared publication - Gil Jae Pyo
Department of Dermatology, College of Medicine, Konyang University, Daejeon, Korea
1 shared publication - Han Young Ryu
Konyang Univ Hosp, Dept Thorac & Cardiovasc Surg, Daejeon, South Korea
1 shared publication
Latest Publications
- Open Access
- 5 May 2025
- Published by Bentham Science Publishers Ltd. in The Open Rheumatology Journal
- Vol. 19 (1)
Severe Lower Limb Edema Complicating COVID-19 in a Rheumatoid Arthritis Patient: A Case Report
Background: COVID-19 is primarily associated with acute respiratory symptoms but can also cause non-respiratory complications, such as lower limb edema. The mechanisms behind this remain unclear, posing diagnostic challenges for clinicians. Case Presentation: A 73-year-old woman with rheumatoid arthritis developed severe lower limb edema following COVID-19. The edema, attributed to systemic inflammation and hypoalbuminemia, was successfully treated with corticosteroids and diuretics. Conclusion: This case highlights the importance of a thorough differential diagnosis of lower limb edema post-COVID-19. After excluding thrombosis and lymphedema, we concluded that systemic inflammation and hypoalbuminemia were the primary contributors. Thus, early recognition and targeted treatment are crucial for managing such cases.
- 5 May 2025
- Published by Bentham Science Publishers Ltd. in The Open Rheumatology Journal
- Vol. 19 (1)
Open AccessSevere Lower Limb Edema Complicating COVID-19 in a Rheumatoid Arthritis Patient: A Case Report
Background: COVID-19 is primarily associated with acute respiratory symptoms but can also cause non-respiratory complications, such as lower limb edema. The mechanisms behind this remain unclear, posing diagnostic challenges for clinicians. Case Presentation: A 73-year-old woman with rheumatoid arthritis developed severe lower limb edema following COVID-19. The edema, attributed to systemic inflammation and hypoalbuminemia, was successfully treated with corticosteroids and diuretics. Conclusion: This case highlights the importance of a thorough differential diagnosis of lower limb edema post-COVID-19. After excluding thrombosis and lymphedema, we concluded that systemic inflammation and hypoalbuminemia were the primary contributors. Thus, early recognition and targeted treatment are crucial for managing such cases.
- Open Access
- 1 February 2024
- Published by Springer Nature in Scientific Reports
- Vol. 14 (1) , 1-10
Detection of novel drug-adverse drug reaction signals in rheumatoid arthritis and ankylosing spondylitis: analysis of Korean real-world biologics registry data
This study aimed to detect signals of adverse drug reactions (ADRs) associated with biological disease-modifying antirheumatic drugs (DMARDs) and targeted therapies in rheumatoid arthritis (RA) and ankylosing spondylitis (AS) patients. Utilizing the KOrean College of Rheumatology BIOlogics & Targeted Therapy Registry (KOBIO) data, we calculated relative risks, excluded previously reported drug-ADR pairs, and externally validated remaining pairs using US Food and Drug Administration (FDA) Adverse Event Reporting System (FAERS) and single centre’s electronic health records (EHR) data. Analyzing data from 2279 RA and 1940 AS patients, we identified 35 significant drug-ADR pairs in RA and 26 in AS, previously unreported in drug labels. Among the novel drug-ADR pairs from KOBIO, 15 were also significant in the FAERS data. Additionally, 2 significant drug-laboratory abnormality pairs were found in RA using CDM MetaLAB analysis. Our findings contribute to the identification of 14 novel drug-ADR signals, expanding our understanding of potential adverse effects related to biological DMARDs and targeted therapies in RA and AS. These results emphasize the importance of ongoing pharmacovigilance for patient safety and optimal therapeutic interventions.
- 1 February 2024
- Published by Springer Nature in Scientific Reports
- Vol. 14 (1) , 1-10
Open AccessDetection of novel drug-adverse drug reaction signals in rheumatoid arthritis and ankylosing spondylitis: analysis of Korean real-world biologics registry data
This study aimed to detect signals of adverse drug reactions (ADRs) associated with biological disease-modifying antirheumatic drugs (DMARDs) and targeted therapies in rheumatoid arthritis (RA) and ankylosing spondylitis (AS) patients. Utilizing the KOrean College of Rheumatology BIOlogics & Targeted Therapy Registry (KOBIO) data, we calculated relative risks, excluded previously reported drug-ADR pairs, and externally validated remaining pairs using US Food and Drug Administration (FDA) Adverse Event Reporting System (FAERS) and single centre’s electronic health records (EHR) data. Analyzing data from 2279 RA and 1940 AS patients, we identified 35 significant drug-ADR pairs in RA and 26 in AS, previously unreported in drug labels. Among the novel drug-ADR pairs from KOBIO, 15 were also significant in the FAERS data. Additionally, 2 significant drug-laboratory abnormality pairs were found in RA using CDM MetaLAB analysis. Our findings contribute to the identification of 14 novel drug-ADR signals, expanding our understanding of potential adverse effects related to biological DMARDs and targeted therapies in RA and AS. These results emphasize the importance of ongoing pharmacovigilance for patient safety and optimal therapeutic interventions.
- Open Access
- 1 July 2022
- Published by Korean College of Rheumatology in Journal of Rheumatic Diseases
- Vol. 29 (3) , 187-189
A Case of Superficial Thrombo-occlusive Vascular Disease in a Patient With Rheumatoid Arthritis
Seong-ji Park, M.D., Chung-il Joung, M.D., Seung Hyun Cheong, M.D., Han Young Ryu, M.D., Ga Hyun Lee, M.D., Gil Jae Pyo, M.D., Mihye Kwon, M.D.. J Rheum Dis 2022;29:187-9. https://doi.org/10.4078/jrd.2022.29.3.187
- 1 July 2022
- Published by Korean College of Rheumatology in Journal of Rheumatic Diseases
- Vol. 29 (3) , 187-189
Open AccessA Case of Superficial Thrombo-occlusive Vascular Disease in a Patient With Rheumatoid Arthritis
Seong-ji Park, M.D., Chung-il Joung, M.D., Seung Hyun Cheong, M.D., Han Young Ryu, M.D., Ga Hyun Lee, M.D., Gil Jae Pyo, M.D., Mihye Kwon, M.D.. J Rheum Dis 2022;29:187-9. https://doi.org/10.4078/jrd.2022.29.3.187
- Open Access
- 1 January 2021
- Published by XMLink in Yonsei Medical Journal
- Vol. 62 (5) , 424-430
Comparison of the 2017 EULAR/ACR Criteria with Clinicoserologic Criteria for the Classification of Idiopathic Inflammatory Myopathies in Korean Patients
Chung SW, et al. Yonsei Med J. 2021 May;62(5):424-430. https://doi.org/10.3349/ymj.2021.62.5.424
- 1 January 2021
- Published by XMLink in Yonsei Medical Journal
- Vol. 62 (5) , 424-430
Open AccessComparison of the 2017 EULAR/ACR Criteria with Clinicoserologic Criteria for the Classification of Idiopathic Inflammatory Myopathies in Korean Patients
Chung SW, et al. Yonsei Med J. 2021 May;62(5):424-430. https://doi.org/10.3349/ymj.2021.62.5.424